510(k) K150819
K150819 is an FDA 510(k) premarket notification submitted by Randox Laboratories Limited for the device "Triglycerides". The FDA issued a decision of Substantially Equivalent on August 6, 2015. The device falls under product code CDT (Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides), a Class I device regulated under 21 CFR 862.1705. Randox Laboratories Limited has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 6, 2015
- Date Received
- March 27, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides
- Device Class
- Class I
- Regulation Number
- 862.1705
- Review Panel
- CH
- Submission Type